Efficacy of initial caspofungin plus trimethoprim/sulfamethoxazole for severe PCP in patients without human immunodeficiency virus infection

BACKGROUND: The number of pneumocystis pneumonia (PCP) cases is increasing in immunocompromised patients without human immunodeficiency virus infection (HIV), causing serious morbidity with high mortality. Trimethoprim/sulfamethoxazole (TMP/SMZ) monotherapy has limited effectiveness in the treatment...

Descripción completa

Detalles Bibliográficos
Autores principales: Qi, Hui, Dong, Danjiang, Liu, Ning, Xu, Ying, Qi, Mengzhi, Gu, Qin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10273704/
https://www.ncbi.nlm.nih.gov/pubmed/37328748
http://dx.doi.org/10.1186/s12879-023-08372-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10273704/
https://www.ncbi.nlm.nih.gov/pubmed/37328748
http://dx.doi.org/10.1186/s12879-023-08372-z

Ejemplares similares